CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. We have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath.
Where appropriate CRiL uses the resources of its two shareholding partners, GSS and Wideblue, as well as external consultants to widen the expertise.
CRiL is ISO 13485 and ISO 9001 accredited by LRQA
CRiL's highly innovative technology has attracted over £1.7 million ($2.5 million) in grants and development contracts, supplementing the significant investment from its shareholders.
· Innovate UK - "Photonics for Health"
· SBRI Healthcare – COPD
· SBRI Healthcare - Medicines Adherence